Parkinson's Disease (PD) is a progressive neurological disorder that affects the movement, balance, and coordination of the body. It is the second most common neurodegenerative disorder after Alzheimer's disease. The most common symptom of PD is tremor in the hands, arms, legs, and face. Other symptoms include stiffness in the muscles, halted movements, difficulty with balance and coordination, impaired cognitive function, and depression. There are several causes of PD, including genetic and environmental factors. Mutations in certain genes are linked to the disease, and environmental factors such as exposure to certain toxins, have also been linked to PD. It is important to note, however, that the cause of PD is not fully understood, and it is likely that a combination of genetic and environmental factors contributes to the development of the disorder. PD is also associated with a number of other medical conditions, including Alzheimer's disease, Lewy body dementia, and multiple system atrophy. These related disorders can involve similar motor symptoms to PD, such as involuntary movements, rigidity, and postural instability, and may share some of the same underlying pathology. Diagnosis of PD typically involves observing the patient's medical history and physical symptoms, and may involve imaging tests such as magnetic resonance imaging (MRI) or computed tomography (CT). Once a diagnosis of PD has been made, there are a number of treatments available to help manage the symptoms of the disorder and to slow its progression. These include medications to reduce tremors and muscle stiffness, and physical and occupational therapies to help improve balance, coordination, and motor skills. Additionally, surgical interventions such as deep brain stimulation may be offered for certain types of PD. While PD-related disorders are not curable, there are many strategies available to help patients manage their symptoms. With the right diagnosis and treatment, people living with PD and PD-related disorders can lead active and fruitful lives.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom